WELCOME TO The PHARMACEUTICAL REPORT
Unlocking iPSCs to Improve CNS Modeling and Drug Discovery
June 15, 2022
I'm For Real
Enter your details once to access all our information and resources
For companies in the global pharmaceutical, medical devices and healthcare industries that require expert advice in regulatory affairs and pharmacovigilance.
whitePaper | October 13, 2022
In our previous edition of the Clinical Trials Roundup1, we explored the acute disruptions that the COVID-19 pandemic brought to the clinical trials landscape in 2020.
whitePaper | October 3, 2022
Next-Generation Synthetic Biology Workflow Platform
Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences.
whitePaper | May 23, 2022
The world’s scientific data today is a morass. 50-80%
of research scientist and data scientist time is spent
wrestling with data before they can focus on highervalue AI/ML and advanced analysis to help bring
new life-saving therapeutics to market.
whitePaper | April 7, 2022
Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way.
whitePaper | June 27, 2022
Welcome to Pharmaprojects' 2022 reviews of trends in pharmaceutical R&D. Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.
whitePaper | June 22, 2022
The technologic and pharmacologic advances that have enabled researchers to take aim at previously untreatable diseases have contributed to an increase in the number of molecules in the development pipeline that are challenging and difficult to manufacture.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE